4,463
Views
14
CrossRef citations to date
0
Altmetric
Systematic review

The spectrum of beta-thalassemia mutations in the 22 Arab countries: a systematic review

, , , &
Pages 109-122 | Received 19 Sep 2020, Accepted 01 Dec 2020, Published online: 29 Dec 2020

References

  • Fibach E, Rachmilewitz EA. Pathophysiology and treatment of patients with beta-thalassemia - an update. F1000Research. 6(2156–):2017.
  • Galanello R, R OR. Beta-thalassemia. Orphanet J Rare Dis. 2010;5(1):11.
  • Thein SL. The molecular basis of β-thalassemia. Cold Spring Harb Perspect Med. 2013;3(5):a011700–a.
  • Origa R. β-Thalassemia. Genet Med. 2017;19(6):609–619.
  • Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480–487.
  • Cappellini MD, Porter JB, Viprakasit V, et al. A paradigm shift on beta-thalassaemia treatment: how will we manage this old disease with new therapies? Blood Rev. 2018;32(4):300–311. .
  • De Sanctis V, Kattamis C, Canatan D, et al. β-Thalassemia distribution in the old world: an Ancient disease seen from a historical standpoint. Mediterr J Hematol Infect Dis. 2017;9(1):e2017018–e. .
  • Hamamy HA, Al-Allawi NAS. Epidemiological profile of common haemoglobinopathies in Arab countries. J Community Genet. 2013;4(2):147–167.
  • Higgs DR, Engel JD, G S. Thalassaemia. Lancet. 2012;379(9813):373–383.
  • Chen W, Zhang X, Shang X, et al. The molecular basis of beta-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity. BMC Med Genet. 2010;11(1):31. .
  • Hajjej A, Almawi WY, Arnaiz-Villena A, et al. The genetic heterogeneity of Arab populations as inferred from HLA genes. PloS One. 2018;13(3):e0192269–e.
  • Ibrahim Z, Makhlouf S. Linguistics in an age of globalization: Perspectives on Arabic language and teaching.  American University in Cairo Press. 2008. ISBN: 9789774161490
  • Panigrahi I, Agarwal S. Genetic determinants of phenotype in beta-thalassemia. Hematology. 2008;13(4):247–252.
  • Zayed H. The Arab genome: health and wealth. Gene. 2016;592(2):239–243.
  • Zayed H. The Qatar genome project: translation of whole-genome sequencing into clinical practice. Int J Clin Pract. 2016;70(10):832–834.
  • Al-Ali M, Osman W, Tay GK, et al. A 1000 Arab genome project to study the Emirati population. J Hum Genet. 2018. DOI:10.1038/s10038-017-0402-y.
  • L Z. The Spectrum of beta-Thalassemia Mutations in the Arab Populations. J Biomed Biotechnol. 2001;1(3):129–132.
  • El-Hazmi MA. al-Swailem AR, Warsy AS. Molecular defects in beta-thalassaemias in the population of Saudi Arabia. Hum Hered. 1995;45(5):278–285.
  • Alotibi RS, Alharbi E, Aljuhani B, et al. The frequency and spectrum of HBB gene mutation in β-Thalassemia patients in Saudi Arabia. Journal of Natural Science, Biology and Medicine. 2019;10(1):97–10.
  • Daar S, Hussein HM, Merghoub T, et al. Spectrum of beta-thalassemia mutations in Oman. Ann N Y Acad Sci. 1998;850:404–406.
  • Hassan SM, Hamza N, Jaffer Al-Lawatiya F, et al. Extended molecular spectrum of beta- and alpha-thalassemia in Oman. Hemoglobin. 2010;34(2):127–134. .
  • Molecular BE. Basis of β-Thalassemia in the United Arab Emirates. Hemoglobin. 2011;35:581–588.
  • Sirdah MM, Sievertsen J, Al-Yazji MS, et al. The spectrum of β-thalassemia mutations in Gaza Strip, Palestine. Blood Cells Mol Dis. 2013;50(4):247–251. .
  • Jassim N, Arrayed S, Al-Mukharraq H, et al. Spectrum of β-thalassaemia mutations in Bahrain. 2000;22(1):8–12.
  • Abuamer S, Shome DK, Jaradat A, et al. Frequencies and phenotypic consequences of association of α- and β-thalassemia alleles with sickle-cell disease in Bahrain. Int J Lab Hematol. 2017;39(1):76–83. .
  • Adekile A, Al-Sherida S, Marouf R, et al. The Sub-Phenotypes of sickle cell disease in Kuwait. Hemoglobin. 2019;43(2):1–5. .
  • Kountouris P, Kousiappa I, Papasavva T, et al. The molecular spectrum and distribution of haemoglobinopathies in Cyprus: a 20-year retrospective study. Sci Rep. 2016;6(1):26371. .
  • Boussiou M, Karababa P, Sinopoulou K, et al. The molecular heterogeneity of beta-thalassemia in Greece. Blood Cells Mol Dis. 2008;40(3):317–319. .
  • Genc A, Tastemir Korkmaz D, Buyukleyla M, et al. Prevalence and molecular analysis of β-thalassemia in Adiyaman, Turkey. Hemoglobin. 2012;36(2):131–138. .
  • Agouti I, Badens C, Abouyoub A, et al. Molecular basis of beta-thalassemia in Morocco: possible origins of the molecular heterogeneity. Genet Test. 2008;12(4):563–568. .
  • Badens C, Martinez Di Montemuros F, Thuret I, et al. Molecular basis of haemoglobinopathies and G6PD deficiency in the Comorian population. Hematol J. 2000;1(4):264–268.
  • R E. Identification and Molecular Characterization of the Most Common Types of Beta Thalassemia Mutations in Sudanese Patients. Am. J. Biomed. Sci. 2019;6: 237–242.
  • MAF E-H, Warsy AS, Al-Swailem AR. The Frequency of 14 β-Thalassemia Mutations in the Arab Populations. Hemoglobin. 1995;19(6):353–360.
  • Rosatelli MC, Tuveri T, Scalas MT, et al. Molecular screening and fetal diagnosis of beta-thalassemia in the Italian population. Hum Genet. 1992;89(6):585–589.
  • Adekile AD, Gu LH, Baysal E, et al. Molecular characterization of alpha-thalassemia determinants, beta-thalassemia alleles, and beta S haplotypes among Kuwaiti Arabs. Acta Haematol. 1994;92(4):176–181. .
  • Villegas A, Ropero P, González FA, et al. The thalassemia syndromes: molecular characterization in the Spanish population. Hemoglobin. 2001;25(3):273–283. .
  • Scerri CA, Abela W, Galdies R, et al. The beta + IVS, I-NT no. 6 (T –> C) thalassaemia in heterozygotes with an associated Hb Valletta or Hb S heterozygosity in homozygotes from Malta. Br J Haematol. 1993;83(4):669–671. .
  • Faustino P, Pacheco P, Loureiro P, et al. The geographic pattern of beta-thalassaemia mutations in the Portuguese population. Br J Haematol. 1999;107(4):903–904. .
  • Adekile A, Haider M, Kutlar F. Mutations associated with beta-thalassemia intermedia in Kuwait. Med Princ Pract. 2005;14(Suppl 1):69–72.
  • Daar S, Gravell D. Diagnosis of Beta-thalassaemia carriers in the sultanate of oman. Sultan Qaboos Univ Med J. 2006;6(1):27–31.
  • Pessar S. Evaluation of twenty four discriminant indices for differentiating beta-thalassemia trait from iron deficiency anemia in Egyptians. Iranian Journal of Pediatric Hematology & Oncology. 2019;9(3):135-146.
  • Old JM, Khan SN, Verma I, et al. A multi-center study in order to further define the molecular basis of β-thalassemia in Thailand, Pakistan, Sri Lanka, Mauritius, Syria, and India, and to develop a simple molecular diagnostic strategy by amplification refractory mutation system-polymerase chain reaction. Hemoglobin. 2001;25(4):397–407.
  • Henderson S, Timbs A, McCarthy J, et al. Incidence of haemoglobinopathies in various populations - the impact of immigration. Clin Biochem. 2009;42(18):1745–1756. .
  • Tadmouri GO, Nair P, Obeid T, et al. Consanguinity and reproductive health among Arabs. Reprod Health. 2009;6(1):17. .
  • Steensma DP, Hoyer JD, Fairbanks VF. Hereditary red blood cell disorders in middle eastern patients. Mayo Clin Proc. 2001;76(3):285–293.
  • Abdaoui W, Benouareth DE, Djenouni A, et al. Genetic background of β-Thalassemia in Northeast Algeria with assessment of the Thalassemia severity score and description of a new β(0)-Thalassemia frameshift mutation (HBB: c.374dup; p.Pro126Thrfs*15). Hemoglobin. 2019;43(4–5):223–228. .
  • Amin SS, Jalal SD, Ali KM, et al. Beta-Thalassemia Intermedia: A Single Thalassemia center experience from Northeastern Iraq. Biomed Res Int. 2020;1:1-11.
  • Jarjour RA, Murad H, Moasses F, et al. Molecular update of β-thalassemia mutations in the Syrian population: identification of rare β-thalassemia mutations. Hemoglobin. 2014;38(4):272–276.
  • El-Shanshory M, Hagag A, Shebl S, et al. Spectrum of Beta Globin Gene mutations in Egyptian Children with β-Thalassemia. Mediterr J Hematol Infect Dis. 2014;6(1):e2014071–e.
  • Hassan TH, Salam MMA, Zakaria M, et al. Impact of Genotype of Beta Globin Gene on hepatic and myocardial iron content in Egyptian Patients with Beta Thalassemia. Indian J Hematol Blood Transfus. 2019;35(2):284–291.
  • Faraon R, Daraghmah M, Samarah F, et al. Molecular characterization of β-thalassemia intermedia in the West Bank, Palestine. BMC Hematol. 2019;19(1):4.
  • Mustafa I, Firdous N, Shebl FM, et al. Genetic epidemiology of beta-thalassemia in the Maldives: 23 years of a beta-thalassemia screening program. Gene. 2020;741:144544.
  • Saeed U, Piracha ZZ. Thalassemia: impact of consanguineous marriages on most prevalent monogenic disorders of humans. Asian Pacific J Trop Disease. 2016;6(10):837–840.
  • Murad H, Moasses F, Dabboul A, et al. Geographical distribution of β-globin gene mutations in Syria. Hematology. 2018;23(9):697–704.
  • Mashi A, Khogeer H, khyatte A, et al. Molecular patterns of β-thalassemia mutations of Saudi patients referred to King Faisal Specialist Hospital and Research Center. Journal of Applied Hematology. 2017;8(3):99.
  • Alaithan MA, AbdulAzeez S, Borgio JF. A comprehensive review of the prevalence of beta globin gene variations and the co-inheritance of related gene variants in Saudi Arabians with beta-thalassemia. Saudi Med J. 2018;39(4):329–335.
  • Al-Ali AK, Al-Ateeq S, Imamwerdi BW, et al. Molecular bases of beta-thalassemia in the Eastern Province of Saudi Arabia. J Biomed Biotechnol. 2005;4:322–325.
  • Abuzenadah AM, Hussein IM, Damanhouri GA, et al. Molecular basis of β-thalassemia in the western province of Saudi Arabia: identification of rare β-thalassemia mutations. Hemoglobin. 2011;35(4):346–357. .
  • Croteau SE, Luo HY, Lehmann LE, et al. Novel dominant β-thalassemia: hb Boston-Kuwait [codon 139/140(+T)]. Pediatr Blood Cancer. 2013;60(10):E131–4. .
  • Al-Obaidli A, Gerard N, Al Zadjali S, et al. A novel deletional beta-thalassemic variant in an ethnic Qatari patient. Hemoglobin. 2009;33(3):214–219. .
  • Hardison RC, Chui DH, Giardine B, et al. HbVar: A relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat. 2002;19(3):225–233. .
  • Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;32(Database issue):D537–D41. .
  • Sadiq MF, Eigel A, Horst J. Spectrum of beta-thalassemia in Jordan: identification of two novel mutations. Am J Hematol. 2001;68(1):16–22.
  • Waye J, Eng B, Got T, et al. Sudanese (δβ)0-Thalassemia: identification and Characterization of a Novel 9.6 kb Deletion. Hemoglobin. 2015;39. DOI:10.3109/03630269.2015.1057736.
  • Agouti I, Bennani M, Nezri M, et al. Beta-thalassemia intermedia due to two novel mutations in the promoter region of the beta-globin gene. Eur J Haematol. 2008;80(4):346–350. .
  • Chibani J, Vidaud M, Duquesnoy P, et al. The peculiar spectrum of beta-thalassemia genes in Tunisia. Hum Genet. 1988;78(2):190–192. .
  • Lemsaddek W, Picanço I, Seuanes F, et al. The beta-thalassemia mutation/haplotype distribution in the moroccan population. Hemoglobin. 2004;28:25–37.
  • Divoka M, Partschova M, Kucerova J, et al. Molecular Characterization of β-Thalassemia in the Czech and Slovak Populations: mediterranean, Asian and Unique Mutations. Hemoglobin. 2016;40(3):156–162. .
  • El-Latif MA, Filon D, Rund D, et al. The beta+-IVS-I-6 (T–>C) mutation accounts for half of the thalassemia chromosomes in the Palestinian populations of the mountain regions. Hemoglobin. 2002;26(1):33–40. .
  • Al-Obaidli A, Hamodat M, Fawzi Z, et al. Molecular basis of thalassemia in Qatar. Hemoglobin. 2007;31(2):121–127. .
  • Fattoum S, Messaoud T, Bibi A. Molecular basis of beta-thalassemia in the population of Tunisia. Hemoglobin. 2004;28(3):177–187.
  • Al-Amodi AM, Ghanem NZ, Aldakeel SA, et al. Hemoglobin A(2) (HbA(2)) has a measure of unreliability in diagnosing β-thalassemia trait (β-TT. Curr Med Res Opin. 2018;34(5):945–951. .
  • Verma IC, Kleanthous M, Saxena R, et al. Multicenter Study of the Molecular Basis of Thalassemia Intermedia in Different Ethnic Populations. Hemoglobin. 2007;31(4):439–452. .
  • Furuumi H, Firdous N, Inoue T, et al. Molecular basis of beta-thalassemia in the Maldives. Hemoglobin. 1998;22(2):141–151. .
  • Makhoul NJ, Wells RS, Kaspar H, et al. Genetic heterogeneity of Beta thalassemia in Lebanon reflects historic and recent population migration. Ann Hum Genet. 2005;69(Pt 1):55–66. .
  • Darwish H, El-Khatib F, Ayesh S. Spectrum of β-globin gene mutations among thalassemia patients in the West Bank Region of Palestine. Hemoglobin. 2005;29:119–132.
  • Al-Ali AK, Al-Ateeq S, Imamwerdi BW, et al. Molecular bases of beta-thalassemia in the Eastern Province of Saudi Arabia. J Biomed Biotechnol. 2005;4:322–325.
  • Boudrahem-Addour N, Zidani N, Carion N, et al. Molecular heterogeneity of beta-thalassemia in Algeria: how to face up to a major health problem. Hemoglobin. 2009;33(1):24–36. .
  • Baysal E. Molecular heterogeneity of beta-thalassemia in the United Arab Emirates. Community Genet. 2005;8(1):35–39.
  • Adekile AD, Haider MZ, Dimovski A, et al. Mutations associated with β-thalassemia intermedia in Kuwait. Blood. 2000;96(11 PART II): 22B-22B.
  • Marwan MM, Scerri CA, Zarroag SO, et al. Comparative In Vivo Expression of β+-Thalassemia Alleles. Hemoglobin. 1999;23(3):221–229. .
  • Rossetti LC, Targovnik HM, Varela V. The molecular basis of beta-thalassemia in Argentina. Influence of the pattern of immigration from the Mediterranean Basin. Haematologica. 2004;89(6):746.
  • El-Harth EH, Kühnau W, Schmidtke J, et al. Identification and clinical presentation of beta thalassaemia mutations in the eastern region of Saudi Arabia. J Med Genet. 1999;36(12):935–937.
  • Çevirici H, Acıpayam C, Dündar Yenilmez E, et al. Investigation of beta globin gene mutations in Syrian refugee patients with thalassemia major. Turk JBiochem. 2019;44(2):126–129. .
  • Murad H, Moassas F, Ali B, et al. A compound heterozygous −29 A>G and IVS-I-1 G>A mutation of HBB gene leading to β-thalassemia intermedia in a Syrian patient: A case repot. Cogent Med. 2019;6. DOI:10.1080/2331205X.2019.1581448.
  • Maryami F, Azarkeivan A, Fallah MS, et al. A Large Cohort Study of Genotype and Phenotype Correlations of Beta- Thalassemia in Iranian Population. Int J Hematol Oncol Stem Cell Res. 2015;9(4):198–202.